脳血管ステントの市場規模、シェア、成長分析：材料別、エンドユーザー別、地域別 - 産業予測 2025～2032年

脳血管ステントの世界市場規模は2023年に4億米ドルと評価され、2024年の4億3,000万米ドルから2032年には8億2,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.3％で成長する見通しです。

脳血管ステント市場は、大脳疾患の有病率の上昇と高齢化により、大きな成長が見込まれています。脳動脈瘤を治療し、狭窄した動脈の適切な血流を確保するために重要なこれらの小さなメッシュチューブは、低侵襲手術技術が普及するにつれてますます利用されるようになっています。ヘルスケア技術の革新は、生体吸収性ステントの採用とともに、市場企業に十分な機会をもたらすと期待されています。しかし、特定のステントの高コストや潜在的な手術合併症などの課題が、市場の拡大を抑制する可能性があります。さらに、新規治療に対する規制当局の承認が増えれば、脳血管ステントに対する需要が高まり、将来有望な市場となる可能性が高いです。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

脳血管ステント市場規模：材料別& CAGR（2025-2032）

• 市場概要
• タンタル
• ステンレス鋼
• ニチノール

脳血管ステント市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 外来手術センター
• 医療センター
• その他

脳血管ステント市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic plc（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Stryker Corporation（USA）
• Johnson & Johnson（USA）
• MicroPort Scientific Corporation（China）
• Penumbra, Inc.（USA）
• Asahi Intecc Co., Ltd.（Japan）
• Integer Holdings Corporation（USA）
• B. Braun Melsungen AG（Germany）
• Biotronik SE & Co. KG（Germany）
• Merit Medical Systems, Inc.（USA）
• Kaneka Medix Corp.（Japan）
• Acandis GmbH（Germany）
• Balt（Switzerland）
• Rapid Medical（Israel）
• Medinol Ltd.（Israel）

結論と推奨事項

Global Cerebral Vascular Stent Market size was valued at USD 0.4 billion in 2023 and is poised to grow from USD 0.43 billion in 2024 to USD 0.82 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The cerebral vascular stent market is poised for significant growth, driven by the rising prevalence of cerebral disorders and an aging population. These small mesh tubes, crucial for treating brain aneurysms and ensuring proper blood flow in constricted arteries, are increasingly utilized as minimally invasive surgical techniques gain traction. Innovations in healthcare technology, along with the adoption of bioabsorbable stents, are expected to present ample opportunities for market players. However, challenges such as the high costs of certain stents and potential procedural complications may restrain market expansion. Moreover, increased regulatory approvals for novel treatments will likely enhance the demand for cerebral vascular stents, positioning the market for a promising future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cerebral Vascular Stent market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cerebral Vascular Stent Market Segmental Analysis

Global Cerebral Vascular Stent Market is segmented by Material, End User and region. Based on Material, the market is segmented into Tantalum, Stainless Steel and Nitinol. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Medical Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cerebral Vascular Stent Market

The rising global geriatric population is a significant driving force behind the expansion of the cerebral vascular stent market. As the number of elderly individuals continues to grow, so does their susceptibility to various cerebral and vascular conditions that necessitate medical interventions. This increasing demographic trend implies a higher demand for cerebral vascular stents to address the health needs of older patients. Consequently, healthcare providers and manufacturers are likely to focus on developing and delivering innovative stenting solutions to cater to the unique requirements of this aging population, ultimately contributing to market growth in the sector.

Restraints in the Global Cerebral Vascular Stent Market

Restraints on the global cerebral vascular stent market include the significant costs associated with cerebral procedures. Surgical interventions involving the brain can be prohibitively expensive due to the requirement for advanced medical technology and the expertise of highly trained healthcare professionals. As a result, these elevated costs are anticipated to hinder the sales growth of cerebral vascular stents in the coming years. Patients may be deterred from undergoing necessary procedures due to financial constraints, ultimately impacting the overall market dynamics and limiting accessibility to crucial treatments for cerebral vascular conditions.

Market Trends of the Global Cerebral Vascular Stent Market

The Global Cerebral Vascular Stent market is experiencing a significant shift towards innovative materials, particularly bioabsorbable stents, which offer the dual benefits of effective vascular support and post-treatment absorption, thereby minimizing the risk of long-term complications. This trend is complemented by the increasing demand for drug-eluting stents that release therapeutic agents, further enhancing treatment outcomes. Together, these developments are fostering a wave of advanced solutions aimed at improving patient safety and recovery. As manufacturers invest in research and development to integrate bioabsorbable materials with drug-eluting technology, the market is poised for substantial growth, driven by enhanced patient-centric solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cerebral Vascular Stent Market Size by Material & CAGR (2025-2032)

• Market Overview
• Tantalum
• Stainless Steel
• Nitinol

Global Cerebral Vascular Stent Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Medical Centres
• Others

Global Cerebral Vascular Stent Market Size & CAGR (2025-2032)

• North America (Material, End User)
  • US
  • Canada
• Europe (Material, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Medix Corp. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medinol Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations